ABVX · Abivax S.A.
$126.70
-4.46 (-3.40%)
Market Cap
$11.43B
Shares
87.16M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-02 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-02 | 2026-06-01 | |
| 6-K | 2026-05-22 | 2026-03-31 | |
| 6-K | 2026-05-20 | — | |
| 6-K | 2026-05-07 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-03-23 | 2025-12-31 | |
| 20-F | 2026-03-23 | 2025-12-31 | |
| 6-K | 2026-02-23 | 2026-02-21 | |
| 6-K | 2025-12-15 | 2025-09-30 | |
| 6-K | 2025-09-08 | 2025-06-30 | |
| 6-K | 2025-07-24 | — | |
| 6-K | 2025-07-22 | — | |
| 6-K | 2025-06-11 | — | |
| 6-K | 2025-06-02 | 2025-03-31 | |
| 6-K | 2025-04-29 | — | |
| 6-K | 2025-04-22 | — | |
| 20-F | 2025-03-24 | 2024-12-31 | |
| 6-K | 2025-03-24 | 2024-12-31 | |
| 6-K | 2025-01-10 | — | |
| 6-K | 2024-12-23 | — | |
| 6-K | 2024-11-19 | — | |
| 6-K | 2024-11-14 | 2024-09-30 | |
| 6-K | 2024-10-03 | — | |
| 6-K | 2024-10-03 | — | |
| 6-K | 2024-09-26 | — | |
| 6-K | 2024-09-25 | — | |
| 6-K | 2024-09-09 | — | |
| 6-K | 2024-09-09 | 2024-06-30 | |
| 6-K | 2024-08-06 | — | |
| 6-K | 2024-07-16 | 2024-07-15 | |
| 6-K | 2024-06-04 | — | |
| 6-K | 2024-05-07 | — | |
| 20-F | 2024-04-05 | 2023-12-31 | |
| 6-K | 2024-04-02 | — | |
| 6-K | 2024-02-02 | — | |
| 6-K | 2024-01-22 | — |
Showing 1–38 of 38 filings
Key facts
CIK
1956827
CUSIP
00370M103
13F (30d)
35 filings
35 filers
Visit website
Investor relations